Neutralization heterogeneity of United Kingdom and South-African SARS-CoV-2 variants in BNT162b2-vaccinated or convalescent COVID-19 healthcare workers
Résumé
There are concerns about neutralizing antibodies (NAbs) potency against SARS-CoV-2 variants. Despite decreased NAb titers elicited by BNT162b2-vaccine against VOC202012/01 and 501Y.V2 strains, 28/29 healthcare workers (HCW) had a NAb titer ≥1:10. In contrast, six months after COVID-19 mild-forms, only 9/15 (60%) of HCW displayed detectable NAbs against 501Y.V2 strain.
Domaines
Médecine humaine et pathologie
Fichier principal
Marot et al. - 2021 - Neutralization heterogeneity of United Kingdom and.pdf (287.13 Ko)
Télécharger le fichier
Origine : Fichiers produits par l'(les) auteur(s)